Complexes containing pyridine-2-carboxaldehyde (pyca) ligand acting as kappa(2)-(N,O) chelates in [MX(CO)(3)(pyca)] (M = Mn, Re; X = Cl, Br), or [MoX(methallyl)(CO)(2)(pyca)] (X = Cl, Br), are good precursors for iminopyridine complexes derived from amino esters and peptides of formula [MX(CO)(3)(py-2-C(H)=NCHX-COOY)] or [MoX(methallyl)(CO)(2)(py-2-C(H)=NCHX-COOY)], via Schiff condensation of the aldehyde function of pyca with the terminal NH2 group of the amino ester or peptide. X-ray determinations confirm the structures and show that in solid phase the peptide chains assemble through H-bonds adopting different patterns which depend on the geometry of the metal-ligand fragments. The H-bonding patterns have been analyzed in detail and described by using graph set methods. In most cases, Mo complexes show intramolecular arrangement involving the halogen (Cl or Br) and an NH group of the side chain. For the Mn and Re complexes, the peptide side arms form infinite chains, helices, and rings. In many cases, the terminal carboxylic O-H function is engaged in a "terminal" H-bond with a polar molecule of solvent (THF or acetone), instead of forming the usual head-to-head arrangement found in simple carboxylic acids. For the longer tripeptide Gly-Gly-Gly, a discrete, dimeric association is observed, in which the peptide chains show antiparallel arrangement with a complementary disposition of the internal N-H and C=O functions. DOSY experiments in solution show significant changes in the diffusion rates upon addition of OPBu3, which indicate H-bonding interaction of OPBu3 with the peptide hydrogens.